( Even if Medicare Part B approves your B12 shots, you may still owe a copay
Officially, the FDA cites: Insufficient large-scale clinical trials Concerns about consistency, sourcing, and manufacturing standards The need to meet formal drug approval requirements Critics argue (fairly) that this system: Favors large pharmaceutical companies Makes it hard to approve naturally occurring peptides Leaves promising, low-risk compounds in regulatory limbo The short version: This FDA restrictive regulatory change of mind wasnt driven by a sudden safety scare, it was driven by regulatory process and economics
Reduced physical discomfort: Some early preclinical research suggests that BPC-157 may have nociceptive (pain relieving) properties
Thats where vitamin B12 injections come in
The agency said such discrepancies raise concerns about the safety of the trial subjects and the reliability of the trial data.
Where a value is not yet published it is shown as Available on documentation or Pending. For laboratory research use only BPC-157/TB-500 20mg is intended solely for laboratory research use by qualified research professionals